Detalhe da pesquisa
1.
Long-term outcomes of neoadjuvant trastuzumab emtansine + pertuzumab (T-DM1 + P) and docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP) for HER2-positive primary breast cancer: results of the randomized phase 2 JBCRG20 study (Neo-peaks).
Breast Cancer Res Treat
; 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38767786
2.
Phase III study of long-term prognosis of estrogen receptor-positive early breast cancer treated with neoadjuvant endocrine therapy with/without adjuvant chemotherapy.
Breast Cancer Res Treat
; 199(2): 231-241, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36947277
3.
Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer.
Breast Cancer Res Treat
; 202(3): 473-483, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37688665
4.
The impact of PIK3CA mutations and PTEN expression on the effect of neoadjuvant therapy for postmenopausal luminal breast cancer patients.
BMC Cancer
; 23(1): 384, 2023 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37106324
5.
Efficacy and exploratory biomarker analysis of entinostat plus exemestane in advanced or recurrent breast cancer: phase II randomized controlled trial.
Jpn J Clin Oncol
; 53(1): 4-15, 2023 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36398439
6.
Differences in Transient Fluid Retention and Lymphedema With Breast Cancer Treatment for Lymphatic Microsurgery.
Ann Plast Surg
; 91(1): 104-108, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37450868
7.
Switch maintenance endocrine therapy plus bevacizumab after bevacizumab plus paclitaxel in advanced or metastatic oestrogen receptor-positive, HER2-negative breast cancer (BOOSTER): a randomised, open-label, phase 2 trial.
Lancet Oncol
; 23(5): 636-649, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35405087
8.
Efficacy of the eribulin, pertuzumab, and trastuzumab combination therapy for human epidermal growth factor receptor 2-positive advanced or metastatic breast cancer: a multicenter, single arm, phase II study (JBCRG-M03 study).
Invest New Drugs
; 39(1): 217-225, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32833136
9.
Clinical impact of the biology of synchronous axillary lymph node metastases in primary breast cancer on preoperative treatment strategy.
J Surg Oncol
; 123(7): 1513-1520, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33684224
10.
A randomized, 3-arm, neoadjuvant, phase 2 study comparing docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP), TCbHP followed by trastuzumab emtansine and pertuzumab (T-DM1+P), and T-DM1+P in HER2-positive primary breast cancer.
Breast Cancer Res Treat
; 180(1): 135-146, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31953696
11.
Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study.
Breast Cancer Res Treat
; 173(1): 123-133, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30242578
12.
Palbociclib in combination with fulvestrant in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-3 subgroup analysis of Japanese patients.
Int J Clin Oncol
; 24(3): 262-273, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30392115
13.
Double-hit follicular lymphoma diagnosed due to central nervous system symptoms.
Ann Hematol
; 102(5): 1281-1282, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36971807
14.
Noninvasive screening test for detecting early stage lymphedema using follow-up computed tomography imaging after cancer treatment and results of treatment with lymphaticovenular anastomosis.
Microsurgery
; 37(8): 910-916, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28621805
15.
Prognostic factors of HER2-positive breast cancer patients who develop brain metastasis: a multicenter retrospective analysis.
Breast Cancer Res Treat
; 149(1): 277-84, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25528021
16.
[Administration Order of FEC-DOC in Breast Cancer Adjuvant Chemotherapy Has an Effect on Toxicity].
Gan To Kagaku Ryoho
; 42(9): 1081-5, 2015 Sep.
Artigo
em Japonês
| MEDLINE | ID: mdl-26469164
17.
Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis.
Breast Cancer Res Treat
; 147(1): 103-12, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25106661
18.
Genomic Landscape of Circulating Tumor DNA in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Treated With Abemaciclib: Data From the SCRUM-Japan Cancer Genome Screening Project.
JCO Precis Oncol
; 8: e2300647, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38635933
19.
Clinical Impact of Fine Needle Aspiration Cytology on Sentinel Node Biopsy after Preoperative Chemotherapy for Core Needle Biopsy-Proven Metastatic Lymph Nodes.
Acta Cytol
; 67(4): 378-387, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36796341
20.
Utility of the intraflap perfusion procedure for abdominal free flap in unilateral breast reconstruction.
J Plast Reconstr Aesthet Surg
; 84: 54-61, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37320952